insights_auto
Outlook: 48.3% bullish·17.2% bearish
Go to analysischevron_right
NVS:NYSE
Novartis AG
$150.47
arrow_downward
-0.50%(-0.75) 1D
$150.00
arrow_downward
-0.31% (-0.47)bedtimeAfter hours
Closed: Nov 20, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 5 analysts giving stock ratings to NVS in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVS in the last 3 months.
Highest
Current $150.47
$180.00 (+19.63%)
Average
$153.75 (+2.18%)
Lowest
$136.00 (-9.62%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs | Sell | Maintained | $136.00 | -9.6% | 11/20/2026 |
Sachin Jain Bank of America Securities | Buy | Maintained | - | - | 11/19/2026 |
Thibault Boutherin Morgan Stanley | Buy | Maintained | $163.00 | +8.3% | 10/28/2026 |
Rajesh Kumar HSBC | Hold | Upgraded | $136.00 | -9.6% | 09/10/2026 |
Steve Scala TD Cowen | Hold | Maintained | $180.00 | +19.6% | 09/08/2026 |
Kerry Holford Berenberg Bank | Hold | Maintained | $147.00 | -2.3% | 07/27/2026 |
Jasper Hellweg Argus Research | Buy | Maintained | $170.00 | +13% | 07/24/2026 |
Justin Smith Bernstein | Hold | Initiated | - | - | 03/19/2026 |
David Toung Argus Research | Buy | Upgraded | $180.00 | +19.6% | 03/11/2026 |